Obesity is a multifactorial chronic disease that comprises several pathological events, such as adipose hypertrophy, fatty liver and insulin resistance. Inflammation is a key contributer to development of these events, and therefore, targeting inflammation is increasingly considered for management of obesity and its complications. | Silibinin attenuates adipose tissue inflammation and reverses obesity and its complications in diet-induced obesity model in mice